Despite significant advances in nuclear medicine for diagnosing and treating prostate
cancer (PCa), research into new ligands with increasingly better biological properties is still …

Simple Summary Controversy exists regarding prostate cancer (PC) screening using the
prostate-specific antigen (PSA) test. It may reduce PC mortality risk but is associated with …

Importance The US Preventive Services Task Force guidelines advise against prostate-
specific antigen (PSA) screening for prostate cancer in males older than 69 years due to the …

Well-done cooked red meat consumption is linked to aggressive prostate cancer (PC) risk.
Identifying mutation-inducing DNA adducts in the prostate genome can advance our …

Purpose Currently, there are no accurate markers for predicting potentially lethal prostate
cancer (PC) before biopsy. This study aimed to develop urine tests to predict clinically …

Prostate cancer (PCa) is the second most common cancer in men and one of the leading
causes of cancer-related deaths. Early detection is the key to successful treatment and …

To improve prostate cancer (PCa) diagnosis, it is imperative to identify novel biomarkers and
establish effective screening techniques. Here, we introduce electrochemical biosensing of …

Background Women with endometrial or ovarian cancer experience a variety of symptoms
during chemotherapy. Patient-Reported outcomes (PROs) can provide insight into the …

Background: Current prostate cancer evaluation can be inaccurate and burdensome.
Quantitative evaluation of Magnetic Resonance Imaging (MRI) sequences non-invasively …

Importance There is no consensus in prostate-specific antigen (PSA) screening guidelines
regarding transgender women despite their known prostate cancer risk. Objective To identify …